L & S Advisors Inc purchased a new stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 52,551 shares of the real estate investment trust’s stock, valued at approximately $4,066,000.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Cloud Capital Management LLC bought a new stake in Ventas in the third quarter worth $25,000. GoalVest Advisory LLC bought a new stake in Ventas in the fourth quarter worth $26,000. Wiser Advisor Group LLC bought a new stake in Ventas in the third quarter worth $27,000. Wilmington Savings Fund Society FSB boosted its holdings in Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 180 shares in the last quarter. Finally, Quent Capital LLC bought a new stake in Ventas in the third quarter worth $39,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Ventas
In related news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by company insiders.
Ventas Stock Down 2.8%
Ventas (NYSE:VTR – Get Free Report) last announced its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s quarterly revenue was up 22.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities research analysts expect that Ventas, Inc. will post 3.86 earnings per share for the current year.
Ventas Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s dividend payout ratio is 378.18%.
Analyst Ratings Changes
VTR has been the subject of a number of recent analyst reports. BMO Capital Markets restated an “outperform” rating and set a $100.00 price target on shares of Ventas in a report on Monday, May 4th. Morgan Stanley set a $90.00 price target on shares of Ventas in a report on Friday, February 13th. Cantor Fitzgerald restated an “overweight” rating and set a $93.00 price target on shares of Ventas in a report on Monday, February 9th. Citigroup upped their price target on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a report on Friday, May 1st. Finally, Jefferies Financial Group upped their price objective on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.00.
Get Our Latest Analysis on VTR
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
